About Daiichi Sankyo Cancer Enterprise The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by three pillars including our investigational Antibody Drug Conjugate Franchise, Acute Myeloid Leukemia Franchise and Breakthrough Science, we aim to deliver seven distinct new molecular entities over eight years during 2018 to 2025. Our powerful research engines include two laboratories for biologic/immuno-oncology and small molecules in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA.
The Manager, Medical Information and Education will support GMA TA/franchise in developing and reviewing global high-quality medical information documents and ensuring accuracy and scientific balance. As part of the GMA review team, the manager is responsible for conducting comprehensive medical review and approval of medical information and training materials/programs. The Manager leverages his/her functional and technical expertise to assist in improving organizational effectiveness of the Medical Information and Education function.
Develop high quality, scientifically sound Global Medical Information Documents, to fulfill unsolicited requests for information coming from Regional /Local Medical Affairs
Manage Medical information Guidance Documents and Medical Q+As through the complete drafting, review and approval process incorporating (input/recommendations from other reviewers (e.g., Peer Reviewers, Legal Affairs reviewer, Supervisor) and discussing with other functions as needed
Develop Medical Education content, including but not limited to internal training materials and external slide decks for use by Regional Medical Affairs, and execute global-regional training programs
Conduct comprehensive medical review and clearance of materials/programs as member of the GMA review team. Ensure comprehensive, high quality, medical review and appropriate sign-off/approval of materials/programs in a timely fashion
Attend review meetings, when applicable
Collaborate closely with GMA TA lead, the Publication lead and/or HEOR and Regional MA function as needed to discuss content and scientific rigor of materials/programs and to assure alignment in Global /Regional Medical Affairs
Consult with supervisor as needed
Serve as integral member of the Global Medical Affairs Team, to Staff Medical Information booths at targeted medical conferences participate in projects/initiatives within GMA or across functions, as assigned. Conduct inquiry analyses, develop Global Medical Information Reports and assist in providing customer insights
Qualifications Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
PharmD strongly preferred
Minimum of 1-year experience in a medically-related field including industry experience in Medical Affairs (experience in medical review and/or medical information is strongly preferred). Proven track record of working successfully with cross-functional teams to achieve results.
Strong oral and written communication skills
Strong relationship management skills; ability to work well within an international and cross-functional team and influence without authority; solid negotiation skills
Firm grasp of pharmaceutical industry and relevant areas that impact it as well as applicable regulations
Experience in collaborating with others to bring projects to completion and lead in informal roles;
Highly proficient in recognizing needs, prioritizing work, multi-tasking and working in fast paced environment
Demonstrated excellence in a medical information support role and/or medical review role, utilizing prudent judgment
Proficiency in maintenance of databases in support of Medical Affairs functions. Proficiency in Microsoft Office Suite of Technologies (Word, Excel, PowerPoint, Project etc.).
Ability to travel up to 20%
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
Internal Number: 9555BR
About Daiichi Sankyo, Inc.
Join a Legacy of Innovation 110 Years and Counting!
With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with a Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.